Healthcare
May 8, 2020
Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That's when most drugs get price tags.
May 6, 2020
Austin, T.X. – As the COVID-19 pandemic worsens and many Texans approach two months since job loss—the deadline to enroll in an ACA Marketplace plan for someone who lost their coverage when they lost their job—U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, will hold a virtual press conference tomorrow to share the steps consumers need to take (and when to take them) to get covered, local resources available, and important updates on Medicaid.
May 6, 2020
Gilead Sciences Inc faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.
May 6, 2020
The Justice Department has opened a criminal investigation into Blue Flame Medical, a firm created by two well-connected Republican operatives who started selling medical supplies this spring as the novel coronavirus spread across the country.
May 6, 2020
Gilead has rocketed into the public consciousness with one of the most promising coronavirus treatments, but the company’s history of sky high drug pricing is drawing increasing scrutiny from Congress about how much it will charge for remdesivir and who will get access.
May 4, 2020
Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, led Members in urging Gilead CEO Daniel O’Day to detail the company’s plans for remdesivir, including securing and scaling up the supply chain, complete disclosures of taxpayer investment in the development of the drug, and purchase and pricing arrangements. As remdesivir—which has been developed with significant taxpayer investment—receives FDA emergency use authorization, the lawmakers questioned its affordability and accessibility for patients.
March 6, 2020
Today, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, released the following statement commending Austin Mayor Adler’s courageous decision to cancel SXSW. Rep. Doggett said:
March 4, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, released the following statement on the emergency coronavirus supplemental appropriations package that the House is set to consider today:
March 2, 2020
A person once quarantined at Joint Base San Antonio-Lackland but released into the larger community tested “weakly positive” for the virus that causes COVID-19, health officials confirmed Sunday.
March 2, 2020
Last Tuesday, Dr. Nancy Messonnier, the Centers for Disease Control (CDC) medical specialist responsible for respiratory diseases, told the unsettling truth about the coronavirus: “We will see community spread in this country...it’s not so much a question of if this will happen, but rather... exactly when this will happen....Disruption to everyday life may be severe.”